Skip to content
Biosnap

Biosnap

  • Finance
  • Cancer Biology
  • Molecular Biology
  • Neroscience
  • About Us
  • Contact Us

Sammaan

10.75% Sammaan Capital NCD FEB-2025

February 24, 2025 by Zahoor Ahmad

Sammaan Capital Limited, A Leading Player in India’s Financial Services Sector, is launching its Tranche III Non-Convertible Debants (NCD) Issue in FEB-2025. With a base issue size of ₹ 100 crus and a green shoe option of ₹ 200 years, this Secure NCD Offering is aimed at Providing Stable Returns to Investors. This article reviews … Read more

Categories Finance Tags Capital, FEB2025, NCD, Sammaan Leave a comment

Recent Posts

  • 10 WORST Performing Mutual Funds in the Last 15 years (4.4% to 9.0% Cagr Returns)
  • Motilal Oswal Launches BSE 1000 Index Fund Nfo – Should You Invest?
  • Top News and Market Movers This Week: 6th Jun ‘2025
  • Use your subconscious mind to build wealth in 20 years – our wealth insights
  • Market Stories in Charts | Kuvera

Categories

  • Cancer Biology
  • Finance
  • Molecular Biology
  • Neroscience

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • September 2024

Categories

  • Cancer Biology
  • Finance
  • Molecular Biology
  • Neroscience
  • Home
  • Terms & Conditions
  • Privacy & Policy
  • Disclaimer
  • About Us
  • Contact Us
© 2025 Biosnap • Built with GeneratePress